How do you approach the development of an LGL clone in a NHL patient actively getting therapy?
1 Answer
Mednet Member
Medical Oncology · University of Rochester Medical Center
Answered on
Most likely, i would monitor the clone and continue with the ongoing treatment plan. This is assuming the size of the clone was relatively small and that the patient was asymptomic in this regard. The development of a T-cell or NK-cell clone isnt necessarily indicative of a separate disease, does no...
Join for free or sign in to see the full answer